tiprankstipranks

Paul Stacey Insider Profile

4 Followers
Paul Stacey, Chief Executive at Advanced Oncotherapy, holds 9.01M shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Paul Stacey Bought 4,666,667p shares of Advanced Oncotherapy on Feb 27, 2012 for an estimated value of 70.00K.
tipranks
Paul  Stacey

Paul Stacey
Advanced Oncotherapy (AVO)
Chief Executive

Not Ranked
Paul Stacey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Paul Stacey does not currently own shares as a corporate insider.
A breakdown of Paul Stacey's holdings

Insider Roles

Paul Stacey does not currently hold a role as a corporate insider.
Roles that Paul Stacey holds in companies

Most Profitable Insider Trade

Stock:
Advanced Oncotherapy
(AVO)
Rating:Informative Buy
Date:Feb 27, 2012 - Feb 27, 2013
Return:-45.20%
The most profitable trade made by Paul Stacey

Paul Stacey's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AVO
Advanced Oncotherapy
Feb 27, 2012
Informative Buy
70.00K
£157.59K
GB:AVO
is no longer traded
Success Rate for
AVO
0 out of 1 profitable transactions on
AVO
0%
Average Return for
AVO
Average return per transaction on
AVO
-45.20%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 27, 2012
Informative Buy
£70.00K
-
£2.00
-45.20%
List of latest transactions for each holding click on a transaction to see Paul Stacey's performance on stock

Paul Stacey insider profile FAQ

What is the percentage of profitable transactions made by Paul Stacey?
The percentage of profitable transactions made by Paul Stacey is ―.
    What is the average return per transaction made by Paul Stacey?
    The average return per transaction made by Paul Stacey is ―.
      What stocks does Paul Stacey hold?
      Paul Stacey holds: GB:AVO stocks.
        What was Paul Stacey’s latest transaction?
        Paul Stacey latest transaction was an Informative Buy of 70.00K.
          What was Paul Stacey's most profitable transaction?
          Paul Stacey’s most profitable transaction was an Informative Buy of GB:AVO stock on February 27, 2012. The return on the trade was -45.20%.
            What is Paul Stacey's role in Advanced Oncotherapy?
            Paul Stacey's role in Advanced Oncotherapy is Chief Executive.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.